Abstract
Shigellosis is a serious public health issue. Millions of people suffer from this deadly food and water borne disease each year. The main manifestations of affected persons are bloody diarrhea with excessive dehydration. The causative agent of this disease is the bacteria Shigella spp. which has four serogroups. Though Shigella flexneri and Shigella dysenteriae are the dominant serogroups in developing countries, reports of other serogroups, namely Shigella boydii and Shigella sonnei, in the food contaminations are available. There are seasonal variations of Shigella infection throughout the world. In Asian subcontinent, monsoon and post monsoon times are the ideal for infection. The transmission of the bacteria in human is usually caused by feco-oral route or by contaminated food and water. There are several groups of antibiotics like foscomycin, macrolide, amiglycoside, tetracycline etc. which were used before. But they are now become useless as Shigella spp. is getting resistant against those drugs. The quinolone groups of antibiotics like ciprofloxacin, ofloxacin, norflxacin, ceftriaxone etc. are the important drugs for the cure of the disease shigellosis but prevalence of drug resistant strains of Shigella spp. against those drugs are a great concern nowadays. The occurrence of plasmid mediated quinolone resistance genes (PMQR), efflux pump proteins and effective mutations at drug binding region of gyrA etc. are the major mechanisms for the development of drug resistance.
Highlights
Shigellosis is a serious public health issue
Though Shigella flexneri and Shigella dysenteriae are the dominant serogroups in developing countries, reports of other serogroups, namely Shigella boydii and Shigella sonnei, in the food contaminations are available
There are several virulence factors and enterotoxins which confer the pathogenicity of the bacteria Shigella, the causative agent of this disease
Summary
Infection due to the Shigella spp. were estimated to be about 170 million per year with about 1 million deaths in developing countries, 69% of them are children under 5 years[2] This number has decreased but it has remained one of the important heath threat around the world. World Health Organization (WHO) estimated that 164.7 million cases of shigellosis occurred per year of which 1.1 million cases result in death in developing countries due to the poor hygiene, limited access of clean water and malnutrition. There are number of antibiotics recommended by WHO for the treatment of shigellosis which reduce the number of deaths per year but the extensive use of them led to an increase in isolation of multidrug-resistant Shigella spp. in several countries .
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
